Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
34.1 USD | -0.28% | -1.73% | -10.26% |
05-09 | Inhibrx, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
02-28 | Inhibrx Shares Fall After Q4 Net Loss Widens | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-10.26% | 1.79B | |
+12.19% | 116B | |
+12.29% | 106B | |
-8.65% | 23.89B | |
-1.69% | 21.58B | |
-10.60% | 18.96B | |
-41.25% | 16.96B | |
-15.32% | 16.33B | |
+6.38% | 14.14B | |
+28.70% | 12.02B |
- Stock Market
- Equities
- INBX Stock
- News Inhibrx, Inc.
- Inhibrx Completes Phase 1 Dose Escalation of INBRX-105 in Patients With Solid Tumors, Draws Additional $60 Million in Debt